U.S. Food & Drug Administration (FDA) CBER's Biologics Guidances and Rules Update

Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components; Guidance for Industry (PDF - 279KB) 
Posted: 8/26/2016
UCM518213.pdf